Literature DB >> 23041063

Recovery of mature hepatocytic phenotype following bile ductular transdifferentiation of rat hepatocytes in vitro.

Masayuki Sone1, Yuji Nishikawa, Yasuharu Nagahama, Eriko Kumagai, Yuko Doi, Yasufumi Omori, Toshiaki Yoshioka, Takuo Tokairin, Masayuki Yoshida, Toshihiro Sugiyama, Katsuhiko Enomoto.   

Abstract

We previously demonstrated that mature rat hepatocytes transdifferentiate to bile ductular cells when cultured in a three-dimensional collagen-rich matrix. Here, we show that the phenotype of transdifferentiated hepatocytes can be reversed by modulating culture conditions. Spheroidal aggregates of hepatocytes were cultured within a collagen gel matrix in the presence of serum and tumor necrosis factor-α. Spheroids transformed into ductular structures composed of small cuboidal cells, lost the expression of hepatocytic markers, whereas aberrantly expressed bile ductular markers. The transdifferentiated cells were then retrieved from the gels, plated on surfaces coated with a basement membrane-like material, and cultured in serum-free media. Cells spontaneously formed spheroidal aggregates and recovered hepatocytic phenotype. Dexamethasone (Dex), which suppressed the phosphorylation of ERK and Jun N-terminal kinase, facilitated the recovery, and the combination with interleukin-6 or oncostatin M resulted in the recovery of hepatocyte nuclear factor 4 α protein expression and the typical hepatocytic morphology, and a decrease in the expression of bile ductular markers. A cDNA microarray analysis revealed that the hepatocyte-specific mRNA expression profile was recovered in these cells. Our results demonstrate that hepatocytes are able to recover their phenotypes following bile ductular transdifferentiation, suggesting that hepatocytic and bile ductular phenotypes may be mutually reversible.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041063     DOI: 10.1016/j.ajpath.2012.08.034

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  5 in total

1.  Immunohistochemical study for the origin of ductular reaction in chronic liver disease.

Authors:  Sun-Jae Lee; Jae-Bok Park; Kyung-Hyun Kim; Woo-Ram Lee; Jung-Yeon Kim; Hyun-Jin An; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Immunohistochemical Analysis of the Stem Cell Marker LGR5 in Pediatric Liver Disease.

Authors:  Zahida Khan; Anne Orr; George K Michalopoulos; Sarangarajan Ranganathan
Journal:  Pediatr Dev Pathol       Date:  2017 Jan-Feb

3.  Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.

Authors:  Miki Nishio; Keishi Sugimachi; Hiroki Goto; Jia Wang; Takumi Morikawa; Yosuke Miyachi; Yusuke Takano; Hiroki Hikasa; Tohru Itoh; Satoshi O Suzuki; Hiroki Kurihara; Shinichi Aishima; Andrew Leask; Takehiko Sasaki; Toru Nakano; Hiroshi Nishina; Yuji Nishikawa; Yoshitaka Sekido; Kazuwa Nakao; Kazuo Shin-Ya; Koshi Mimori; Akira Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

4.  Biliary fibrosis drives liver repopulation and phenotype transition of transplanted hepatocytes.

Authors:  Mladen I Yovchev; Joseph Locker; Michael Oertel
Journal:  J Hepatol       Date:  2016-02-05       Impact factor: 25.083

5.  SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury.

Authors:  Daiki Yoshii; Keita Shimata; Yuji Yokouchi; Yoshihiro Komohara; Hiroko Suda; Masaki Honda; Kenichi Yamamura; Taizo Hibi; Yukihiro Inomata
Journal:  Hum Cell       Date:  2022-02-12       Impact factor: 4.174

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.